Orbimed closes $500m venture fund
The New York-based firm says investors flocked to its third fund to focus on late-stage life science companies.
31 December 2012•2 mins read
The New York-based firm says investors flocked to its third fund to focus on late-stage life science companies.
The largest funds take a growing share of total PE fundraising
24 hours ago · 2 mins read
Side Letter: Mid-alignment
29 October 2026 · 3 mins read
Side Letter: Software stress
28 October 2026 · 3 mins read
Ardian bets on the ‘power of live’ in latest buyout fund
28 October 2026 · 3 mins read
Advent’s $27bn flagship: How it stacks up against PE’s biggest funds
27 October 2026 · 2 mins read
Apax eyes March 2027 first close for Fund XII
27 October 2026 · 2 mins read
Side Letter: Roads less traveled
27 October 2026 · 5 mins read
